XXIII. Literaturliste

(Die Literaturliste wird hier wie im Original wiedergegeben. Wenngleich sie für die meisten Leser entbehrlich sein dürfte, so wird doch der interessierte Fachmann Zugang zu den meisten Materialien finden können)


Agranoff, B.W. 1974,

Diet and the geographical distribution of multiple sclerosis.

Lancet, p. 1061-1066.


Alter, M., Leibowitz, U. and Spector, J., 1966,

Risk of multiple sclerosis related to age at immigration.

Arch. Neurol., 15, p. 234-237.


Alter, M., Okihiro, M., Rowley, W. and Morris, T., 1971,

Multiple sclerosis among Orientals and Caucasians in Hawaii.

Neurology, v. 21, p. 122-130.


Alter, M., Yamoor, M. and Harashe, M., 1974,

Multiple Sclerosis and nutrition.

Arch. Neur., v. 31, p. 267-272.


Alter, M., 1977,

Clues to the cause based upon the epidemiology of multiple sclerosis.

in Field, E.J. (ed.). Multiple Sclerosis: A critical conspectus.

Lancaster, MTP Press Ltd., p. 35-81.


Balch, J.F. and Balch, P.A., 1996,

Prescription for nutritional healing,

2nd edition. Avery Publishing Group, New York, 600 p.


Bansil, S., Cook, S.D. and Rohowsky-Kochan, C., 1995, Multiple Sclerosis: immune mechanism and update on current therapies.

Annals of Neurology, v. 37, p. S87-S101.


Bates, D., 1989,

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis.

Journal of Neurology, Neurosurgery and Psychiatry, v. 52, p. 18-22.


Bateson-Koch, C., 1994,

Allergies-Disease in disguise.

Alive Books, Burnaby.


Belluzzi, A. et al., 1996,

Effect of an enteric-coated fish oil preparation on relapses in Crohn's Disease.

N. Engl. J. Med., v. 334, p. 1557-1560.


Benedikz, J., Magnusson, H. and Guomundsson, G., 1994,

Multiple Sclerosis in Iceland with observations on the alleged epidemic in the Faroe Islands.

Annals of Neurology, v. 36, supplement 2, p. S175-S179.


Bengtsson, U. et al., 1996,

Non IgE-mediated food allergy.

Gut., v. 39, p. 130-135.


Butkus, S.N. and iVIahan, L.K., 1986,

Food allergies: immunological reactions to food.

N. Am. Dietetic Assoc. Cont. Ed., p. 601-608.


Carter, J.L., 1995,

Disease modifying therapies in multiple sclerosis.

CNS Drugs, v. 3, p. 99-114.


Cochrane, C.G, and Koffler, D., 1973,

Immune complex disease in experimental animals and man.

Adv. Immunology, v. 16, p, 185.


Compston, A., 1991,

Limiting and repairing the damage in multiple sclerosis.

Jour. of Neurology, Neurosurgery and Psychiatry, v. 54, p.945-948.


Dean, G. and Kurtzke, J., 1971,

On the risk of multiple sclerosis according to age at immigration to South Africa.

BMJ, v. 3, p. 725-729.


Detre, Z. et al., 1986,

Studies on vascular permeability in hypertension: action of anthocyanosides.

Clin. Physiol. Biochem. n. 4, p. 143-149.


Dworkin, R.H., Bates, D., Millar, J.H.D. and Paty, D.W., 1984,

Linoleic acid and multiple sclerosis: a reanalysis of three double blind trials.

Neurology, v. 34, p. 1441-1445.


Eaton, S.B. and Konner, M., 1985,

Paleolithic Nutrition: A consideration of its nature and current implications.

New England Journal of Medicine, v. 312, p. 283-2S9.


Ebers, G.C., 1996,

Genetic epidemiology of multiple sclerosis.

Current Opinion in Neurology and Neurosurgery.


Ebers, G., Bulman, D., Sadovnick, A. et al., 1986,

A population-based study of MS-twins.

N. Engl. J. Med., v. 315, p. 163S-1642.


Ebers, G., Sadovnick, A.D. and Risch, N.J., 1995,

A genetic basis for familial aggregation in multiple sclerosis.

Nature v. 377, p. 150-151.


Elgert, K.D., 1996,


John Wiley and Sons, New York, 468 p.


Elian, M., Nightingale, S. and Dean, G., 1990,

Multiple sclerosis among the United Kingdom-born children of immigrants from the Indian subcontinent, Africa, and the West Indies.

J. Neurol Neurosurg Psychiatry, v. 53, p. 906-911.


Erasmus, U., 1993,

Fats that heal, fats that kill.

Alive Books, Burnaby, B.C., Canada.


Gell, P.G.H. and Coombs, R.R.A., 1975,

Classification of allergic reactions responsible for hypersensitivity and disease.

In Clinical Aspects of Immunology, P.Gell, R. Coombs and P. Lachmann (eds.). New York, Blackwell, p. 761-781.


Gerrard, J.A. and Zaleski, A., 1976,

Functional bladder capacities in children with enuresis and recurrent urinary infections.

In Clinical Ecology, L. Dickey (ed.). Springfield, Illinois, Charles C. Thomas, p. 224-233.


Goldberg, P., Fleming, M.C. and Picard, E.H., 1986,

Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

Medical Hypotheses, v. 21, p. 193-200.


Graham, J., 1989,

Multiple sclerosis - a self-help guide to its management.

Healing Arts Press, Rochester, Vermont.


James, P.B., 1982,

Evidence for subacute fat embolism as the cause of multiple sclerosis.

Lancet, p. 3S0-385.


Johnson, D., Seeldrayers, P.A. and Weiner, H.L., 1988,

The role of mast cells in demyelination 1 myelin protein are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation.

Brain research, v. 444, p. 195-19S,


Kermode, A.G,, Tofts, P.S., Thompson, A.J. et al., 1990,

Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.

Neurology, v. 40, p. 229-235,


Kruger, P.G., BH, L., Myhr, K.M. et al., 1990.

Mast cells and multiple sclerosis: a light and electron microscope study of mast cells in multiple sclerosis emphasizing staining procedures.

Acta. Neurol, Scand., v. 81, p. 31-36.


Kruger, P.G. and Nyland, H.I., 1995,

The role of mast cells and diet in the onset and maintenance of multiple sclerosis: a hypothesis.

Medical Hypotheses, v. 44, p. 66-69.


Kuroiwa, Y., Shibasaki, H. and Ikeda, M,, 1983,

Prevalence of MS and north-south gradient in Japan.

Neuroepidemiology, v. 2, p. 62-69.


Kurtzke, J.F., 1977,

Multiple sclerosis from an epidemiological point of view

in. Field, E.J. (Ed.), Multiple Sclerosis: A critical conspectus. MTP Press Inc., Lancaster, p. S3-142.


Kurtzke, J.F., 1980,

Epidemiologic contributions to multiple sclerosis: an overview.

Neurology, v. 30, p. 61-79.


Kurtzke, J.F., 1995,

MS epidemiology worldwide. One view of current status.

Acta. Neurol. Scandin., Supplement 161, p. 23-33.


Lai, M. et al., 1996,

A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis.

Journal of Neurology, Neurosurgery and Psychiatry, v. 60, p. 339-341.


Lauer, K., 1994,

The risk of multiple sclerosis in the USA in relation to sociogeographic features: a factor analytic study.

J. Clin. Epidemiology, v. 47, p. 43-4S.


Lichtenstein, L.M., 1993,

Allergy and the immune system.

Scientific American, v. 269, p. 117-124,


MacDougall, R., 1980,

My fight against multiple sclerosis.

Regenics Inc., Mansfield, Ohio.


Macknin, M.L. et al., 1996, Zinc lozenges shorten duration of common cold.

Ann. Intern. Med, v. 125, p. 81-88.


Malosse, D,, Perron, H. and Seigneurin, J.M., 1992,

Correlation between milk and dairy product consumption and multiple sclerosis prevalence, a worldwide study.

Neuroepidemiology, v. 11, p. 304-312.


Meyer, M.G., Johnston, A. and Coca, A.F., 1954,

Is Multiple Sclerosis a manifestation of idioblaptic allergy?

The Psychiatric Quarterly, Jan. p. 1-15.


Millar, J.H.D., 1975, Clinical management:

Linoleic acid diet.

In Multiple Sclerosis Research, New York, Elsevier, p. 217-225.


Miller, D.H., Rudge, P.Johnson, G. et al., 1988,

Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.

Brain, v. 111, p. 927-939.


Mumford, C., Wood, N., Kellar-Wood, H. et al., 1994,

The British Isles Survey of multiple sclerosis in twins.

Neurology, v. 44, p. 11-15.


Oro, A.S. et al., 1996,

Regulation of disease susceptibility: decreased prevalence of IgE mediated allergic disease in patients with multiple sclerosis.

J. Allergy Clin. Immunology, v. 97, p. 1402-1408.


Ostenstad, B., Dybwad, A., Lea, T., Forre, O., Vinje, O. and Sioud, M., 1995,

Evidence for monoclonal expansion of synovial T cells bearing VO2.1/VA5.5 gene segments and recognizing a synthetic peptide that shares homology with a number of putative autoantigens.

Immunology, v. 86, p. 168-175.


Poser, C.M., 1986,

Pathogenesis of multiple sclerosis.

Acta Neuropathol., v. 71, p. 1-10.


Poser, C., 1987,

Trauma and multiple sclerosis.

J. Neurol. v. 254, p. 155-159.


Poser, C"1992,

Multiple sclerosis. Observations and reflections - a personal memoir,

J. Neuro. Sci., v. 107, p. 127-140.


Poser, C., 1993,

The pathogenesis of multiple sclerosis. Additional considerations.

J. Neuro. Sci., v. 115 (suppl.) p. S3-S15.


Poser, C.M., 1994,

The epidemiology of multiple sclerosis: a general overview,

Ann. Neurology, v. 36, p. S181-S193.


Poser, C. et al., 1988,

An analysis of the "epidemic" of MS in the Faroe Islands.

I. Clinical and epidemiological aspects. Neuroepidemiology, v. 7, p. 168-1SO.


Rafei, A.E., Peters, S.M., Harris, N. et al., 1989,

Diagnostic value of IgG4 measurements in patients with food allergy.

Ann. Allergy, v. 62, p. 94-99.


Robert, A.M. et al., 1977,

Action of anthocyanosides of vaccinium myrtillis on the permeability of the blood-brain barrier.

Journal of Medicine, v. 8, p. 321-332.


Rosati, G., 1994,

Descriptive epidemiology of multiple sclerosis in Europe in the 19SOs: a critical overview.

Annals of Neurology, v. 36, p. S164-S174.


Rozniecki, J.J., Hanser, S.L,, Stein, M. et al., 1995,

Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients.

Ann. of Neurology, v. 37, p. 63-66.


Sadovnick, A.D. and Ebers, G., 1993,

Epidemiology of multiple sclerosis: a critical overview.

Can. Jour. Neur. Sci., v. 20, p. 17-29.


Sampson, H.A., 1991,

Immunologic mechanisms in adverse reactions to foods.

Immunology and Allergy Clinics of North America, v. 11, p. 701-716.


Shakib, F., Brown, H,M., Phelps, A, and Redhead, R., 1986,

Study of IgG sub-class antibodies in patients with milk intolerance.

Clin. Allergy, v. 16, p. 451-458.


Shatin, R., 1964,

Multiple Sclerosis and geography.

Neurology, v. 14, p. 338-344.


Shoab, B.O. and Patten, B.M., 1996,

Human adjuvant disease: presentation as a multiple sclerosis-like syndrome.

South. Med. J., v. 89, p, 179-188.


Sibley, W.A., Bamfield, C.R. and Clark, K., 1985,

Clinical viral infections and multiple sclerosis.

Lancet, p. 1313-1315.


Sibley, W.A., 1992.

Therapeutic claims in multiple sclerosis.

Demos Publications, New York, New York, 202 p.


Singh, V.K., Yamaki, K., Donoso, L. and Shinohara, T., 1989,

Yeast histone H3-inducedexperimental autoimmune uveitis.

Journal of Immunology, v. 142, p. 1512-1517.


Smith, A.D. and Thompson, R.H.S., 1977,

Lipids and multiple sclerosis.

In Multiple Sclerosis: A critical Conspectus. Lancaster, MTP Press Ltd., p. 225-244.


Soll, R.W., 1968,

Delayed hypersensitivity: a possible mechanism in the etiology of multiple sclerosis

in Alter, M. and Kurtzke, J. (eds.). The epidemiology of multiple sclerosis. C.C.Thomas, Springfield, Illinois, p. 110-128,


Soll, R.W. and Grenoble, P.B., 19S4,

MS - Something can be done and you can do it.

Contempory Books, Chicago, Illinois,


Steinman, L., 1993,

Autoimmune Disease.

Scientific American, v. 269, p. 107-114,


Swank, R.L. and Dugan, B.B., 19S7,

The Multiple Sclerosis diet book,

Doubleday, Garden City, New York.


Swank, R.L. and Dugan, B.B., 1990,

Effect of low saturated fat diet in early and late cases of multiple sclerosis.

Lancet, v. 336, p. 37-39.


Theofilopoulos, A.N., 1995a,

The basis of autoimmunity: Part II Genetic predisposition.

Immunology Today, v. 16, p. 150-158.


Theofilopoulos, A.N., 1995b,

The basis of autoimmunity: Part I Mechanisms of aberrant self-recognition.

Immunology Today, v. 16, p. 90-98.


Thomas, R., 1995,

The Natural Way-Multiple Sclerosis.

Element Books Ltd., Rockport, MA, 133 p.


Thompson, R.H.S., 1975,

Unsaturated fatty acids in multiple sclerosis.

In Multiple Sclerosis Research. New York, Elsevier, p. 184-197.


Traugott, U., 1990,

Evidence for Immunopathogenesis.

in, Handbook of Multiple Sclerosis, S.D. Cook (ed.). Marcel Dekker Inc., New York, p. 101-127.


van Oosten, B.W., Truyen, L., Barkhof, F. and Polman, C.H., 1995,

Multiple sclerosis therapy, a practical guide.

Drugs, v. 49, p. 200-212.


Weiner, H., Mackin, G., Matsui, M. et al., 1993,

Double-blind pilot trial of oral tolerance with myelin antigens in multiple sclerosis.

Science, v. 293, p. 1321-1324.


Wolinsky, J.S., 1995,

Copolymer 1: an editorial.

Neurology, v. 45, p. 1245-1247.


Wucherpfennig, K.W,, 1995,

Molecular mimicry in T cell-mediated autoimmunity: viral peptides ac tivate human T cell clones specific for myelin basic protein.

Cell, v. 80, p. 695-705.


Zurier, R.B. et al., 1996,

Rheumatoid arthritis symptoms improve with gamma-linolenic acid.

Arthritis Rheum., v. 39, p. 1808-1817.


Dieses Material ist als allgemeine medizinische Information gedacht und nicht als Ratgeber für den individuellen Patienten vorgesehen; es will und kann den Rat des Arztes nicht ersetzen. Jede Art von Verantwortung für Folgen, die aus eigenem Handeln aufgrund dieses Aufsatzes entstehen, muß zurückgewiesen werden.


International MS Support Foundation

P.O. Box 90154

Tucson, Arizona 85752-0154